MOVE News

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there were a few bright spots, led by biotechs Design Therapeutics (DSGN) and Ikena Oncology...read more

Movano, which is developing a wearable device that measures glucose, blood pressure, and heart rate, raised $43 million by offering 8.5 million shares at $5, as expected. The company offered 1.3 million more shares than anticipated. At pricing, the company commands a fully diluted market value of $171 million. Movano is developing a proprietary platform that uses radio...read more

Movano, which is developing a wearable device that measures glucose, blood pressure, and heart rate, announced terms for its IPO on Wednesday. The Pleasanton, CA-based company plans to raise $36 million by offering 7.2 million shares at $5. At the proposed price, Movano would command a fully diluted market value of $164 million. Movano is developing a proprietary...read more

The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. TELUS International (TIXT) upsized and priced at the high end to raise $925 million at a $6.6 billion market cap. The company provides outsourced...read more